clinical trial · NCT07519577
A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-2）
Keymed Biosciences Co.Ltd·phase2·not yet recruiting·n = 120
Chronic Rhinosinusitis With Nasal PolyposisCM512
brief summary
This is an open-label, single-arm, multicenter, expansion study to evaluate the safety and efficacy of CM512 in patients With Chronic Rhinosinusitis with Nasal Polyposis
started
May 31, 2026
primary completion
May 31, 2028
completion
May 31, 2028
last updated
Apr 9, 2026
official title
An Open-Label, Single-Arm, Multicenter, Expansion Study to Evaluate the Safety and Efficacy of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol